CSCC treatment: Systemic therapy

touchMDT for touchONCOLOGY

Listen in as a dermato-oncologist and a dermatologist consider when to use systemic therapies to treat patients with locally advanced or metastatic CSCC, using a patient case to illustrate the emerging role of immunotherapy in clinical practice.

The multidisciplinary team

• Dermato-oncologist: Dr Joël Claveau, Canada
• Dermatologist: Prof. Caroline Robert, France

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.com/mdt-optimizing-cscc-management